Mancia Ko, PharmD, MBA

Head of Medical Affairs
Collegium Pharmaceutical
Stoughton, Massachusetts

Presentation(s):

• Poster Number-46 - Celecoxib Oral Solution in the Acute Treatment of Migraine: Pooled Efficacy and Safety Results From 2 Randomized Placebo-controlled Trials

  Poster Abstracts

• Poster Number-13 - Consistency of Response to Liquid Celecoxib in Adults With Migraine: Post Hoc Analysis of Results From Two Randomized, Placebo-Controlled Studies

  Poster Abstracts

• Poster Number-14 - Efficacy of Celecoxib Oral Solution in Adults With and Without Baseline Nausea: Post-Hoc Analysis of Results From Two Randomized, Double-Blind Placebo-Controlled Trials in the Acute Treatment of Migraine

  Poster Abstracts

• Poster Number-47 - Impact of Celecoxib Oral Solution on Symptomatic Improvements in the Acute Treatment of Migraine

  Poster Abstracts

• Poster Number-12 - Treatment Effects of Celecoxib Oral Solution in Migraine With Aura and Without Aura: Post-Hoc Analysis of Results From Two Randomized, Double-Blind Placebo-Controlled Trials

  Poster Abstracts

• Poster Number-79 - udget Impact Analysis of Xtampza® ER (oxycodone extended-release) for the Treatment of Chronic Pain from a Managed Care Perspective

  Poster Abstracts